| Identification | Back Directory | [Name]
ETHYL 2-(4-CHLOROPHENYLAMINO)-4-THIAZOLECARBOXYLATE | [CAS]
165682-93-9 | [Synonyms]
O4I2
O412
O4I2, >98%
O4I-2;O4I 2
O4I2 >=98% (HPLC)
ETHYL 2-(4-CHLOROPHENYLAMINO)-4-THIAZOLECARBOXYLATE
ethyl 2-(4-chlorophenylamino)thiazole-4-carboxylate
ethyl 2-(4-chloroanilino)-1,3-thiazole-4-carboxylate
2-[(4-chlorophenyl)amino]-4-thiazolecarboxylic acid ethyl ester
4-Thiazolecarboxylic acid, 2-[(4-chlorophenyl)amino]-, ethyl ester | [Molecular Formula]
C12H11ClN2O2S | [MDL Number]
MFCD08166530 | [MOL File]
165682-93-9.mol | [Molecular Weight]
282.75 |
| Chemical Properties | Back Directory | [Boiling point ]
408.1±51.0 °C(Predicted) | [density ]
1.382±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [solubility ]
DMSO:20.0(Max Conc. mg/mL);70.7(Max Conc. mM) | [form ]
A crystalline solid | [pka]
1.48±0.10(Predicted) | [color ]
Light yellow to yellow | [InChI]
1S/C12H11ClN2O2S/c1-2-17-11(16)10-7-18-12(15-10)14-9-5-3-8(13)4-6-9/h3-7H,2H2,1H3,(H,14,15) | [InChIKey]
ULUBAPWNHROTEU-UHFFFAOYSA-N | [SMILES]
O=C(OCC)C1=CSC(NC2=CC=C(Cl)C=C2)=N1 |
| Hazard Information | Back Directory | [Uses]
O4I2 is a potent inducer of Oct3/4 expression. | [Biological Activity]
O4I2 is a potent inducer of the Octamer-binding transcription factor 4 (Oct3/4) in various human cell lines including human fibroblasts. In principle O4I2 could be a useful tool for chemical-mediated induction of pluripotency in somatic cells. | [Synthesis]
GENERAL METHODOLOGY: General procedure for the preparation of ethyl 2-((4-chlorophenyl)amino)thiazole-4-carboxylate: a mixture of ethyl 3-bromopyruvate (2.14 g, 11 mmol) and 1-(4-chlorophenyl)thiourea (0.75 g, 10 mmol) was milled in the presence of Na2CO3 (0.50 g) for 5-6 min. The reaction process was monitored by TLC. After completion of the reaction, water (20 ml) was added to the reaction mixture and subsequently extracted with chloroform (20 ml). The separated organic layer was dried with anhydrous sodium sulfate. Excess solvent was removed by distillation. The crude product was filtered and crystallized from aqueous ethanol to give pure solid product in 83% yield. Similarly, other derivatives can be prepared according to the above method and their structures were confirmed by comparison of melting points with literature values. | [storage]
Store at -20°C | [References]
[1] Journal of Medicinal Chemistry, 2015, vol. 58, # 15, p. 5742 - 5750
[2] European Journal of Medicinal Chemistry, 2016, vol. 123, p. 718 - 726
[3] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 17, p. 4979 - 4984 |
|
|